Development of a validated Western blot method for quantification of human dystrophin protein used in phase 2 and 3 clinical trials of eteplirsen for the treatment of Duchenne muscular dystrophy

Saved in:
Bibliographic Details
Published in:Neuromuscular disorders : NMD 2017-03, Vol.27, p.S16-S16
Main Authors: Schnell, F.J, Donoghue, C, Dworzak, J, Charleston, J, Frank, D, Wilton, S, Fletcher, S, Lewis, S, Mendell, J.R, Rodino-Klapac, L.R, Sahenk, Z
Format: Article
Language:English
Subjects:
Neurology
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0960-8966
DOI:10.1016/S0960-8966(17)30264-X